In lung and pancreatic ductal adenocarcinoma (LUAD and PDAC), KRAS mutation frequency reaches ~ 25 and 90% of cases respectively [1, 2]. This evidence concerns the gene KRAS and pancreatic ductal adenocarcinoma.